The Karmanos Cancer Institute and Wayne State University School of Medicine in Detroit will head a $9 million cancer study to better understand how the disease disproportionately affects African Americans.
The study is backed by National Cancer Institute and will include 5,560 cancer survivors. The study aims to create better understanding of why African Americans experience higher cancer incidence rates and higher cancer mortality rates.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
"Disparities in cancer survivorship that disproportionately burden African Americans are the product of the complex interactions occurring among genetic and biological factors and social, behavior and environmental factors," said Ann G. Schwartz, PhD, professor and deputy director of the Karmanos Cancer Institute. "It is crucial that we better understand why African Americans are often diagnosed with cancer at higher rates and why survival after that diagnosis is lower than in other populations."
More articles on quality:
How the ACA affected access to primary care: 5 things to know
Exercise test inaccurately identifies open heart surgery candidates, study
NY gov. seeks to cut funds from 39 public health programs